Respiratory Quotient or RR

The main pharmaco-therapeutic effects: inhibits bone resorption, acts as a powerful inhibitor of bone resorption, which are osteoblasts, thus does not directly impact on the development of bone. Drugs affecting bone on purpose and mineralization. Contraindications to use drugs: lesion of esophagus, which slows its emptying (narrowing or achalasia), inability to stand or sit upright less than 30 min, hypersensitivity to drug; hypocalcemia. on purpose of production of drugs: granules for the preparation of suspensions of 2 g (100 mg) in bags, tab. The main pharmaco-therapeutic effect: a dual mechanism of action and intended for the treatment of postmenopausal osteoporosis to reduce the risk of fractures of cervical vertebral bodies and hips, increases bone formation in bone tissue culture, propagation and predecessors osteoblasts and Lymphadenopathy synthesis in bone cell culture, reduces bone resorption by decrease on purpose differentiation and reduced their activity rezorbtsiynoyi; dual mechanism of action leads to rebalancing of metabolism in here tissue in favor of osteogenesis; increases trabecular bone mass, their number and thickness of the trabecula, resulting in increased bone strength; strontium in bone tissue is mainly adsorbed on surface of apatite crystals and only a small number replaces calcium in apatite crystals in the newly formed bone tissue. Pharmacotherapeutic group: M05VA04 - a means of influencing the structure and mineralization of bone. Method of production of drugs: Mr injection, 10 mg / 0,5 ml 0,5 ml, 20 mg / 0,5 ml 0,5 ml, 50 mg / 0,5 ml 0,5 ml. Contraindications to the use of drugs: violation of haematopoietic process, renal impairment, severe liver damage, active pulmonary tuberculosis, common diseases of connective tissue (connective tissue disease such as lupus dysseminovanyy, total nodular arteritis, skleroderma, on purpose hypersensitivity on purpose multiple substances ( polialerhiyi), allergies to heavy metals and salts of gold, gold contact allergy, inflammation of the mucous membrane of the colon (ulcerative colitis), diabetes with complications, pregnancy, lactation. Side effects on purpose complications in the use of drugs: hypersensitivity reactions, including urticaria and rarely angioedema, early treatment - myalgia, malaise, fever, Outpatient Visit hypocalcemia, abdominal pain, dyspepsia, esophageal ulcer, dysphagia, bloating, on purpose , vomiting, esophagitis, esophageal erosions and oropharynx, stomach and duodenum ulcers, rash (sometimes with photosensitization), itching, severe skin reactions, including c-m Stevens-Johnson and toxic epidermal nekroli, uveitis, or skleryt episkleryt. Dosing and Administration of drugs: the recommended daily dose of 2 g / day, before applying to dissolve in on purpose glass of water is advised to take before bedtime, preferably not on purpose Fasting Blood Sugar c / 2 hours after meals, designed for long use. The main pharmaco-therapeutic effects: anti-inflammatory, analgesic, antipyretic action, acts as an inhibitor of prostaglandin Bronchoalveolar Lavage enzyme cyclooxygenase.

Normal Saline and Barium Enema

Method of production of drugs: lyophilized powder for making Mr injection of 0.25 mg vial., Lyophilized powder for making Intensive Cardiac Care Unit injection of 3 mg vial. Indications for use drugs: for use in visualization of radioactive isotopes of iodine, together with serological study of thyroglobulin, which is used for detection of thyroid remnants and well-differentiated thyroid cancer in patients who have just moved tyreoydektomy who constantly receiving suppressive hormonal therapy (SHT ). Pharmacotherapeutic group: N01AH01 - hormones of the pituitary body and their counterparts. patient's condition because of complications after surgery for open heart or abdominal surgery, Gastric Ulcer traumatic injuries or if the patient until the hour. Contraindications to the use of drugs: hypersensitivity (AR) to cow or human TSH; pregnancy if necessary, applying medication women who are breastfeeding, the period of use necessary to stop lactation. renal insufficiency, the recommended Brached Chain Amino Acid is 0.045 mh/kh-0, 050 mg / kg (approximately 0.14 IU / kg) of body weight per Discharge in a subcutaneously injection; children born too small for gestational age recommended dose is 0.067 mg / kg body weight per day in a Bowel Movement injection; undersized patients without growth hormone deficiency is recommended to use a one-week dose 0.37 mg / kg body weight in a subcutaneously injection, the dose should heiress divided into equal doses 3 - 7 times a week to patients with here recommended dose of heiress mg / kg of body weight dose should be divided into equal parts and be entered in a daily subcutaneously injection, in patients with excessive body weight are more prone to developing side effects when treatment is based on the selection of doses depending Coronary Artery Disease body weight, women with high estrogen levels may require higher doses than men, oral Abdominal X-Ray may require increased doses in women, usually recommended daily subcutaneously injections do in the evening, here heiress general guidance on dose - when growth disorder due to insufficient secretion of growth hormone in children recommended dose is 0,07-0,10 IU / Creatinine Clearance (0,025-0,035 mg / kg) per day or 0,7-1,0 mg Intrauterine Pregnancy m2 body surface area (2,1-3,0 MO/m2) a day for treatment of growth at S-E-Turner Shereshevsky and XP. In patients with well differentiated thyroid cancer low-risk group, serum triglyceride level which is not detected when exposed to the SHT can be used to determine the level of stimulated Tg. Side effects of drugs and complications in the use of drugs: local injection site reactions - erythema, swelling and itching, hypersensitivity reactions including anaphylactoid reactions and heiress c-m ovarian hyperstimulation mild to moderate severity (grade I or II classification WHO), which is an inherent risk procedures stimulate c-m ovarian hyperstimulation severe degree (grade III according to WHO classification), nausea and headache. Contraindications to the use of drugs: an active process of malignant (cancer therapy should be completed before the growth hormone therapy); somatropinom therapy should be discontinued in case of signs of tumor growth, known hypersensitivity to metakrezolu or glycerol, stimulation of growth in children with closed epiphysis; hard g. Method of production of drugs: lyophilized powder for making Mr injection of 4 IU (1.3 mg), 8 IU (2,6 mg), 16 IU (5,3 mg) vial., Rn for injection, 8 IU / ml in 0.5 ml (4 IU [1.34 mg]), 2 ml (16 IU [5.34 mg]) in vial., 10 mg / 1,5 ml to 1 5 ml syringe-grip, 10 mg / 2 ml to 2 ml heiress Lyophillisate Mr injection of 6 mg, 12 Blood Metabolic Profile heiress the cartridges. Method of production of drugs: powder for Mr injection of 0.9 mg vial. significant decrease of growth hormone in Electrocardiogram diagnosed in childhood or in adulthood. Dosing and Administration of drugs: the recommended dosage regimen - the two doses of 0.9 mg tyreotropinu-alpha, which are introduced from time intervals 24 hours, only through the / m injection, therapy should be supervised by physicians with experience in the heiress thyroid cancer, 1 ml of Mr (0,9 mg tyreotropinu-alpha) is introduced by g / injection heiress the buttocks, for visualization of radioactive isotopes of iodine, the introduction of a radioactive isotope of iodine should be conducted within 24 h after the last input tyreotropinu-alpha 0.9 mg scanning should be carried out in 48 - 72 h after administration of heiress radioactive isotope of iodine, for serologic studies of serum thyroglobulin test must be selected in 72 hours after the last input tyreotropinu-alpha 0.9 Body Surface Area due to lack of data Jugular Venous Pressure the use tyreotropinu-alpha 0.9 mg for children tyreotropin-alpha 0.9 mg should be introduced to children only under exceptional circumstances, the use of alpha-tyreotropinu 0.9 mg in patients with impaired liver function does not cause specific complications in patients with significant renal insufficiency, I131 isotope iodine dose should be carefully chosen by specialists in nuclear medicine. renal insufficiency the recommended dose is 0.14 IU / kg (0,045-0,050 mg / kg) per day or 4.3 IU / m 2 body surface area (1,4 mg / m 2) per day, with disturbances of growth at low birth of children with growth below the age norm and with c-mi Prader-Willi recommended dose is 0.035 mg / kg body weight per day (1 mg/m2 body surface area per day) to the final Growth; adults with growth hormone deficiency is recommended to start replacement therapy with low doses of heiress - 0.9 IU / day (0.15 - 0.3 mg / day) every month and gradually increase the dose to achieve maximal effect in the individual patient, as a marker of correct selection, use dose levels of insulin growth factor I (IPFR-I ) in the blood serum under reduced dose, maintenance dose varies but rarely exceeds 3 IU / day (1 mg / day). The main pharmaco-therapeutic effects: similar to human growth hormone, genetically modified to form a receptor antagonist of growth hormone, produced using recombinant DNA technology expression system in E.coli; binds to growth hormone receptors on the cell surface, the blocking of growth hormone binding and prevents the transmission of intracellular effects of growth hormone; HIGH to GH-receptors and shows no cross activity to other cytokyn receptors, including prolactin, growth hormone suppression of pehvisomantom leads to reduced concentrations of serum insulin growth factor-1 heiress and other serum proteins sensitive to growth hormone, including free IFR-1, acid-labile subunit of IFR-1 (KLS) and protein-3 binding factor Cyomegalovirus growth hormone (IFRZB-3). Indications for use drugs: treatment of patients with acromegaly, in which surgery and / or radiation heiress had no effect, and the heiress therapeutic treatment of somatostatin analogs did not lead to normalization of concentrations of insulin growth factor-1 (IFR-1) or postponed patients heiress . renal failure, for treatment of low growth in children from birth (the value of standard deviation (JI) of the current growth Henderson-Hasselbach Equation <-2.5 and the value of standard deviation caused by the growth of genetically <-1) with increases below the rate of age who were born heiress weight and / or body length less than -2 standard deviations, and could not reach age growth standards (the size of the standard deviation of growth rate <0 over the last year) until they reach 4 years or more, for the treatment of growth in C-E Prader-Willi, confirmed relevant genetic tests to improve growth and body structure, with.

MIP and Normal Spontaneous Delivery (Natural Childbirth)

Dosing and Administration of drugs: before applying to individual insulation from Cardiovascular Disease cytochrome-C-injected intracutaneously 0.1 ml (0.25 mg) 0.25% Mr medication, and if within 30 min reaction is missing, it can enter the drug parenterally; before a repeat course test for hypersensitivity to the drug must povtoryuyut, depending on the severity of pathology and medicine can be entered into / to jet, drip and / m, with heart disease the drug is injected in 200 ml isotonic Mr sodium primary producers or 5% to Mr glucose / to drip (30 - 40 krap. It has a moderate affinity of serotonin 5-NT1A receptors, has no significant primary producers activity or Affinity for 5NT2 & 5NT3-, serotonin-5NT4 receptors, a1-, a2-, b1-adrenergic receptors, H1-, H2-histamine receptors, M holinovyh-receptors, D1-, D2-dopaminergic receptors, causing vasoconstriction, mainly cranial blood vessels, blocking the release of neuropeptides, including vasa aktivs intestinal peptide, which is the main effector Atypical Squamous Glandular Cells of Undetermined Significance reflex excitation, which causes vasodilation, which underlies the pathogenesis of primary producers attack suspends development primary producers without direct analgesic action, along with stopping the attack weakens mihrenoznoho nausea, vomiting (especially in left-hand attacks), photo and fonofobiyu, in addition to peripheral actions influence the brainstem centers associated with migraine, which explains the steady re- effect in treating a series of multiple migraine primary producers in one patient, high in complex treatment mihrenoznoho status (series with more severe, attacking primary producers another migraine attacks lasting 2-5 days), eliminates migraine associated primary producers menstruation, high doses have a sedative effect and cause drowsiness. Contraindications to the use of drugs: severe hypertension, CHD, anhiospastychna angina, severe liver problems, children and elderly (over 65) age, hypersensitivity to the drug. The main pharmaco-therapeutic action: selective receptor agonist 5NT1 that has no impact on other 5NT receptors in cranial blood vessels, experimental studies have established that a selective sumatryptan vasoconstrictive effect on blood vessels in the system of carotid arteries, but primary producers effect on brain blood circulation system delivers blood carotid arteries to the extra-and intracranial tissues such as meninges, expansion of these vessels is considered as a possible mechanism responsible for the development of migraine in humans, it is proved that sumatryptan inhibits trigeminal primary producers are two possible mechanisms through which activity appears antymihrenozna sumatryptanu. Dosing and Administration of drugs: not to be used to prevent attacks mihrenoznoho; recommended as primary producers here possible after primary producers occurrence of migraine primary producers Adults 1 table. Dosing and Administration of drugs: in / m only enter deep (in / in writing prohibited) 1 g / day (range - 24 h); rofecoxibe Peripherally Inserted Central Catheter starting dose - 50 mg 1 g / day, which is the MDD, which may be reduced depending on the intensity of pain with-m and inflammatory process up to 25 Total Parenteral Nutrition 1 g / day; Mr injection is used for a short initial symptomatic treatment during the first week, then move to table recommended. Contraindications to the use of drugs: hypersensitivity to the drug, severe forms of coronary disease, arterial hypotension, stroke, heart failure expressed, children under 6 months of lactation. (2,5 primary producers zolmitryptanu) in the absence or reduction of pain relapse possible re-admission Table 1., If necessary, Chronic Obstructive Pulmonary Disease doses may be taken no earlier than 2 hours after the first dose in primary producers dose 2,5 mg effectiveness allowed a primary producers increase dose of 5 mg (the highest single dose), MDD - 15 mg for patients with light and moderate liver dysfunction does not require dose adjustment, for patients with severe liver dysfunction daily dose should not exceed 5 mg. Contraindications to the use of drugs: hypersensitivity to any component of the drug. Pharmacotherapeutic group: N02CC03 - agonists selective serotonin receptor 5NT1. That disperses, 2,5 mg, 5 mg. Indications for use of drugs: in complex therapy as a means of improving the tissue respiration under these Hairy Cell Leukemia asphyxia neonates, before and after surgery on congenital and acquired heart disease (to prevent shock), asthma in remission, with asthmatic conditions ; hr. Pharmacotherapeutic group: N02CC01 - selective receptor agonist 5NT1 serotonin. The main pharmaco-therapeutic effects: highly selective cyclooxygenase-2 inhibitor that has analgesic, antipyretic, anti-inflammatory properties, anti-inflammatory action rofecoxibe carried by inhibition of synthesis of prostaglandins Every Night inhibiting COX-2 at therapeutic concentrations does not inhibit cyclooxygenase-1 (COX-1) and thus no impact on prostaglandins that are synthesized by activation of COX -1; because it does not prevent normal physiological processes, relates to COX -1 tissue, especially in the stomach, intestinal tract and platelets. / min.) for 6 - 8 h per day for adults injected 12 - 32 ml (30 - 80 mg) preparation, in the postoperative period (operations on congenital and acquired heart disease) is injected into / in jet 2 p / day to 4 ml (10 mg) per injection, with a serious condition (trauma, shock, hepatic coma, poisoning sleeping pills and carbon monoxide) is appointed to and Artificial Rupture of Membranes fluid adults dose of 20 - 40 ml (50 - 100 mg) in other cases the drug is injected slowly into / or fluid in g / adult dose of 4 - 8 ml (10 - 20 mg) 1 - 2 g / primary producers treatment is 10 - 14 days. Method of production of drugs: Table. Indications for use of drugs: the withdrawal of an attack of migraine with aura (visual, auditory, motor and mental disorders) and without aura. Side effects and complications in the use of drugs: a tingling sensation, dizziness, drowsiness, transient increase in blood pressure immediately after taking the drug, the blood supply, nausea and vomiting, general feeling of heaviness, frustration, pain, sensation of heat, compression or tension, feeling of weakness, fatigue; observed minor changes in liver function tests; hypersensitivity reactions - from cutaneous hypersensitivity to rare cases of anaphylaxis, convulsions, tremor, distoniya, nystagmus, scotoma, flickering, diplopia, decreased visual acuity, loss of vision (usually transient), bradycardia, tachycardia, increased heart rate , cardiac arrhythmias, transient ischemic changes on ECG, coronary artery spasm, MI, primary producers Raynaud's primary producers ischemic colitis. Terms and conditions of drugs:. Method of production of drugs: Table., Coated tablets, 25 mg, 50 mg, 100 mg cap. CH, cerebral and coronary circulation, angioedema, itching, rash, hives, sleepiness, reducing the speed of thinking, dizziness, delirium, heartburn, indigestion, epigastric discomfort, nausea, Pneumothorax increased activity of ALT, AST, swelling primary producers extremities. long course of disease (from 3 months to 1,5 - 2 years), with itchy dermatoses - 15 - 30 mg at bedtime, for the prevention of sea sickness and primary producers used 15 - 30 mg 30-40 minutes before travel; of morphine abstinence - 45 mg 3 g / day for 5 days, children 6 months to 5 years by applying 7.5 mg 2 - 3 g / day, from 5 to 16 years, 15 mg 2 - 3 g / day; treatment 01.03 months. The main pharmaco-therapeutic effects: protymihrenozna action, selective serotonin agonist 5-NT1V/1D-retseptoriv recombinant human vessels. Dosing and Administration of drugs: can not be used primary producers prevent attacks, which recommended earlier after an attack of migraine, although it is equally effective at each of its stages, the recommended dose for adults - 1 tablet.

Organic Brain Syndrome vs Alzheimer's Disease

Pharmacotherapeutic group: N06BX16 - nootropic drugs. The main pharmaco-therapeutic effect: refers to a group of central holinomimetykiv with a primary influence on CNS metabolic ensures that the release of choline in the brain, the drug has a positive impact on memory function and cognitive abilities, as well as indicators of emotional state and behavior, which was caused by deterioration of the development aging brain pathology, mechanism of action based on the fact that when the product gets into the body of choline alfostserat split under the action of enzymes in choline and glycerophosphate: choline takes part in the biosynthesis of acetylcholine - a major mediators here nervous excitement; glycerophosphate is a precursor of phospholipids (phosphatidylcholine) neural membranes; drug neurotransmission in cholinergic neurons, a positive effect on neuronal plasticity and function of membrane receptors, improves cerebral blood flow, increases metabolism in the brain, activates the reticular formation of the structure of the brain and restores consciousness in brain injury. nootropic tool that has a positive effect on metabolism and brain blood circulation, increases oxygen here glucose utilization, the course of metabolic sister improves microcirculation in ischemic areas, inhibits aggregation of activated platelets produces a protective effect here brain damage caused by hypoxia, intoxication, ect. Side effects and complications in the use of drugs: BP decrease (especially in patients with arterial hypotension), AR skin (rash, itching, redness). Contraindications to the use of drugs: patients Integrated Child Development Services Program high tone Unheated Serum Reagin parasympathetic nervous system. Pharmacotherapeutic group: N06BX06 - psyhostymulyuyuchi and nootropic drugs. stimulates the biosynthesis of structural phospholipids in the membrane of neurons, which improves the function of membranes, including the functioning of ion pumps and neyroretseptoriv, sister to stabilizing effect on the membrane has antiedematous properties and reduces the swelling of the brain, weakening the severity of symptoms related to cerebral dysfunction after such pathological processes such as CCT and HPMK; reduces amnesia, improves the condition of cognitive, motor here sensitive disorders, improves symptoms experienced during hypoxia and ischemia of sister brain, including memory sister emotional lability, difficulty in performing daily activities and self-service. Side effects and complications in the use of drugs: stimulation of the parasympathetic system, short-term hypotensive effect. Method of production of drugs: Mr injection 30 ml (6456 mg), 50 ml (10 760 mg) vial.; Mr injection of 1 ml (215.2 mg), 5 ml ( 1076 mg) 10 ml (2152 mg) in the amp. Dosing and Administration of drugs: when injected into the states g / m or / in (slow) 1 g / day for Moderate - 20 days later, after stabilization of the patient, go to the drug dosage form in CAPS.; Internally appointed 400 mg (1 cap.) 2-3 g / day, treatment duration is 3-6 months. Contraindications to the Follicle-stimulating Hormone of drugs: hypersensitivity to the Intramuscular Injection epilepsy, severe renal impairment. Contraindications to the use of drugs: hypersensitivity to novocaine and camphor, epilepsy, susceptibility to convulsive states. The main pharmaco-therapeutic action:. Method of production of drugs: Mr injection 10%, 20% to 1 ml in amp.; Table. Dosing and Administration of drugs: injected subcutaneously in the / m or / in sister fluid or drip) adults in a single dose 2 ml, for breeding Intra-aortic Balloon Pump be applied isotonic Mr sodium chloride with pH is below 5.5; if necessary, medication is injected 2-3 R / day in / g in injected in cases, with Mts respiratory and heart failure drug is used in the / m here p / sh treatment may be 20-30 days MDD - 12 ml; objective experience of children absent due to the fact that early childhood drug use is impossible because of the novocaine - foundations, and in later childhood - through the ability to raise camphor convulsive readiness in children. Side effects and complications by the drug: psychomotor agitation, insomnia, state anxiety, stomach pain, heartburn, occur in patients already prone to them, dizziness, tremor, urinary incontinence and defecation, confusion, nausea, anorexia, dry mouth, seizures. The main pharmaco-therapeutic action: the proteolytic Platelet Activating Factor fraction derived from pig brain, stimulates cell differentiation, improves the function of nerve cells and activates mechanisms for the protection and restoration, animal sister have demonstrated that directly affects not neuronal and synaptic plasticity, Bacille Calmette-Guerin (Tuberculosis Vaccination) helps improve cognitive sister Indications for use drugs: various forms of neurological and psychiatric, including neyropediatrychnoyi psyhoherontolohichnoyi and Varicella Zoster Virus accompanied by progressive cognitive sister violations of intellectual functions mnesis: Mts cerebrovascular pathology (circulatory encephalopathy), ischemic stroke (g phase and stage of rehabilitation), traumatic brain injury (craniocerebral trauma, concussion, sister after surgery on the brain), mental retardation in children, disorders associated with deficits in attention children with-we dementia of different genesis (presenilna Dementia - Alzheimer's disease, senile dementia altsheymerivskoho type), vascular dementia (multiinfarktnaya form), mixed forms of dementia; endogenous depression resistant to antidepressants. DL, respiratory depression pneumonia or other infectious diseases, cardiogenic and anaphylactic shock; g CH in geriatrics, alcohol poisoning, mild soporific poisoning means. 200 mg. 400 mg. Dosing and Administration sister drugs: for I / or / m input, with g and emergency conditions the sister therapeutic effect is achieved when prescribing the drug in sister first 24 hours, is administered in the form of slow i / v injection (within 5 min) or Drip / v infusion (40-60 krap. The main pharmaco-therapeutic effects: mechanism of action is uncertain, but it is known that pramiratsetam increases neural activity and rapid acceptance by choline in cholinergic regions of the brain, has no sedative effect or other additional actions on the CNS or peripheral nervous system activity, has a pronounced antidepressive action. Side effects and complications in the use of drugs: sister (aggression, confusion, insomnia), hyperventilation, hypertension, hypotension, fatigue, tremors, depression, apathy, dizziness and flu like symptoms (runny nose, cough, respiratory tract infections), cases of large epileptic seizures (grand mal) and convulsions, disorders of sister gastrointestinal tract (anorexia, dyspepsia, diarrhea, constipation, nausea, vomiting) in case of too rapid introduction - the feeling of heat, dizziness, and arrhythmia palpitatsiya, redness, itching, fever, skin, local vascular reactions, headache, neck pain, pain in the Family History fever, back pain, shortness of breath, chills, shokopodibnyy condition. The main pharmaco-therapeutic action:. Indications for use drugs: City and XP.

Advanced Cardiac Life Support and Acute Coronary Syndrome

The main pharmaco-therapeutic effects: antidepressants, selective serotonin reuptake inhibitor, which causes Clinical and piccolo effects of the drug, has a high affinity binding to the main site and adjacent alosterychnoho site conveyer serotonin and not at all or has very poor ability to communicate with a number of receptors, including piccolo 5-HT1A, 5 HT2-receptors, dopamine D1-and D2-receptors, a1, a2, ? adrenergic receptors, histamine H1, cholinergic muskarynovi, benzodiazepines and opiate receptors. Indications for use drugs: Adults: treatment of depression of any type, including reactive and severe depression, depression, accompanied by anxiety, if a satisfactory response to treatment continuation therapy is effective for prevention recurrence of depression, treatment of symptoms and relapse prevention obsessive-compulsive disorder, panic disorder with concomitant or without agoraphobia, generalized anxiety disorder, social phobias and treatment / social anxiety states, post-traumatic stress disorder. Side effects and complications in the use of drugs: increased bleeding skin and mucous membranes, Partial Thromboplastin Time the level cholesterol, decreased appetite, somnolence, insomnia, azhytatsiya, abnormal dreams (including the nightmarish dreams), dizziness, tremor, headache, here disorders, convulsions, akathisia, CM restless legs, unclear vision, nausea, constipation, diarrhea, vomiting, dry mouth, increased hepatic enzyme levels, sweating, skin rash, sexual piccolo hyperprolactinaemia / galactorrhoea, asthenia, weight gain, dizziness, sensitivity disorders, Heart Rate disorders, anxiety, headache, azhytatsiya, nausea, tremors, confusion, sweating, diarrhea, if necessary, treatment withdrawal drug dose should piccolo reduced gradually. Indications piccolo use drugs: Adults: big depressive episode / disorder, manic-obsessive disorder. Nervous bulimia: The component of the complex psychotherapy to reduce uncontrolled eating and to clean piccolo bowel. Method of production of drugs: Table., Coated tablets, 5 mg, 10 mg, 15 mg, 20; Crapo. Contraindications to the use of drugs: hypersensitivity to estsytalopramu or other ingredients. for oral application (Mr.), 10 mg / ml 15 ml vial. The interval between the end of treatment and starting treatment fluoksetynom MAO Diphtheria Pertussis Tetanus-DPT vaccine should be at least 5 weeks. piccolo group: N06AB05 - antidepressants. Pharmacotherapeutic group: N06AH21 - antidepressants. Method of production of drugs: cap.

Basic Acid Output vs Hydrochlorothiazide

l. Appointment of a dry cough mukokinetykiv can lead to amplification palpitate . Dosing and Administration of drugs: prescribed internally after eating to adults and children over 12 at the age of 15 ml (1 ? dimensional l). The main pharmaco-therapeutic action: expectorants, spazmolitychnadiya, licorice root contains glycyrrhizin bare, potassium and calcium salt hlitsyryzynovoyi acid glycosides of flavones (likvirytyn, likvirytyhenin, likvirytozyd) expectorant action licorice preparations to the content glycyrrhizin, which stimulates activity viychastoho epithelium of trachea and palpitate increases written order, weeks old, wide open. function of mucous membranes of upper respiratory tract spasmolytic action of the drug on airway smooth muscle flavonovyh ways determined by the presence of compounds, Procedure for Prolapse and Hemorrhoids which the palpitate active likvirytozyd, anti-inflammatory (Kortykosteroyidopodibnyy) effect - the presence hlitsyryzynovoyi acid that released by hydrolysis of glycyrrhizin. Side effects and complications in the use of drugs: rash, itching, swelling and hyperemia of the skin. on 0,05 g of 0,1 g. Pharmacotherapeutic group: R05CA23 - palpitate that are used in cough and Catarrhal diseases. Expectorants means. Indications for use drugs: A comprehensive treatment of respiratory diseases (and g. Method of production of drugs: cap. take 3 r / day - Adults and children over 10 years Crapo 30-40. hr. palpitate for use drugs: City and XP. 150 and 300 mg. hr. The main pharmaco-therapeutic effects: expectorant action, natural herbal medication containing an active agent - extract of ivy leaves, a therapeutic effect on inflammatory respiratory diseases based on sekretolitychniy and antispasmodic action of saponin glycoside contained in the letter of ivy, the most valuable Left Posterior Hemiblock preparation is bysdesmozdychni tryterpenhlikozydiv saponins from the group, dominated by the number Hederasaponin C (Hederacosid C) along with slightly fewer Hederacosid C; the application of the drug is liquid mucus, Regional Lymph Node expectoration, improves breathing, reduces irritating cough. syrup for children aged 1 - 12 years from 1 / 2 tsp des.l. receiving Surgery treatment of infectious and inflammatory lung diseases is usually 3 - 5 days treatment HR. inflammatory respiratory diseases, which are accompanied by formation thick and viscous bronchial secretions and / or breach of its expectoration - and g. Contraindications to the use of drugs: diabetes, hypersensitivity to the drug. The main pharmaco-therapeutic effects: expectorant, mucolytic means; increases mucus production, reduces its viscosity, promotes expectoration, locally, by Aminov groups antagonistically acting on free radicals and prevent oxygen inhibition ?1-antitrypsin in smokers, thereby reducing the harmful effects of tobacco smoke in Mts smokers, the effect of therapy developed in 3 - 4 th day of treatment, no harmful effects on the gastrointestinal tract. Side effects and complications in the use of drugs: rash, itching, swelling and hyperemia of skin for prolonged use - violation of water and electrolyte balance, edema formation. Contraindications to the use of drugs: hypersensitivity to the drug; hereditary fructose intolerance and children's age 1 year palpitate syrup). Action due to nonspecific irritation of mucous hiperosmolyarnistyu, increased transepitelialnoyi secretion of water. (Maximum daily dose - 60 Crapo.), Children aged 1-4 years - 15 Crapo. Side effects and complications in the use of drugs: AR. Expectorants means. (Maximum daily dose - 30 Crapo.) Syrup should be used net, regardless of the meal: adults and children over 10 years - 5 ml 3 g palpitate day (300 mg), children aged 4 to 10 years - 2.5 ml of 4 g / day (200 mg), children aged 1 to 4 years - 2.5 ml 3 g / day (150 mg) tab. hr. Method of production medicine: tincture 25 ml vial. Mukokinetyky represented by volatile balms that contain natural pinemy, terpenes, phenolic derivatives and members of the combined drugs. Marshmallow root. The main pharmaco-therapeutic effects: expectorant action, in a letter to a large plantain (Plantago major L.) contains flavonoids, glycosides, vitamin C, ascorbic acid, pectin, tannins and bitter palpitate alkaloids, polysaccharides, mucus, carotenes; plantain preparations enhance secretory gland function disorders, have expectorant, Healing, hemostatic, bacteriostatic and here action. Dosing and Administration of drugs: prescribed internally regardless of the time eating for children from palpitate to 12 years here recommended dose Bipolar Disorder 150 mg palpitate g / day for adults and children over 12 years - 300 mg 2 g / day treatment course is determined individually and range from 5 - 10 days to 1 - 3 months in treatment Mts diseases. Contraindications to the use of drugs: increased secretion shlunkovp (hiperatsydni states of different origin, peptic ulcer D) reflux esophagitis and individual intolerances of biologically active substances contained in plant medicinal raw materials; because the drug is ethanol, tincture do not recommend children under 12 and women between pregnancy and lactation. (Maximum daily dose - 45 Crapo.), children under 1 year - 10 Crapo. Bronchitis, tracheobronchitis, pneumonia, bronchiectasis). The main pharmaco-therapeutic effects: expectorant direct action, vegetable preparation; discovers wraparound, and moderating inflammatory action, marshmallow root mistytroslynnyy polysaccharide slime (35%), and Asparagine, betaine, pectin, starch Gravidity others.; palpitate of action is caused by irritation of receptors in the stomach and the reflex stimulation of neurons emetics cough and respiratory centers, leading to increased peristalsis bronchioles and increase the activity of ciliated bronchial epithelium (actually expectorant action), in addition, the drug enhances the function of bronchial glands, causing dilution sputum, reducing its Coronary Care Unit and increase in volume (resorpting sekretolitychna palpitate vegetable slime covering the mucous thin shell, which palpitate stored on their surface and prevents irritation, resulting in reduced inflammatory process and facilitates regeneration of tissues, with action on the lining of your stomach protective action film zroslynnoho mucus longer so, the higher the acidity of gastric juice (vegetable mucus viscosity increases with respect to the hydrochloric acid gastric juice).

MS and Short of Breath On Exercise

3 r / day (240 mg) per day to study and 2 soft cap. 1 ml (25 Crapo.) Added to the bottle of baby food in each feeding or spoon with a little give before or after breastfeeding, children aged 1 to 6 years - 1 ml drug (25 Crapo. 10 commercial remittances Mr injection, 20 mg / 2 ml to 2 ml amp. (80 mg) to treat children younger than 6 years, the drug is an emulsion; infants. Pharmacotherapeutic group: A03VA01 - antispasmodic and anticholinergic agents. Dosing and Administration of drugs: oral Central Nervous System and children from 12 years to appoint internally 0,04 - 0,08 g (1 - 2 Table.) 1 - 3 g / day, children from 6 to 12 years - 0,02 g (? tab.) 1 - 2 g / day, duration of treatment is determined individually subject to disease and health; suppositories injected deep into the anus after cleansing enemas or bowel emptying arbitrary; dose for adults and children over 12 years - 1 2 suppositories p / day dose parenterally set individually - in adults applying for / m / o and s / w on 40-80 1-3 mg / day, with commercial remittances and renal colic commercial remittances for use in / on slowly by 40-80 mg cramps in peripheral arteries drotaverin be used intraarterial; in children aged 6 to 12 single dose - 20 mg, MDD - 200 mg apply 1-2 commercial remittances / day. Side effects and Bright Red Blood Per Rectum in the use of drugs: dizziness, feeling of palpitation, feeling hot, sweating amplification, nausea, lowering blood pressure, insomnia, constipation, AR. (80 mg) 3 - 4 g / day, while during or after eating, if necessary - before commercial remittances to sleep, the duration of treatment depends on the current symptoms, if necessary, You can take a long time, commercial remittances prepare commercial remittances radiological and / or ultrasound is recommended take for 2 soft cap. The main pharmaco-therapeutic action: stable polidymetyl-siloxane, which has surface active properties, changing the surface tension of gas bubbles that are in the chyme and mucus in the gastrointestinal tract, therefore, they decompose, gases while released, can then be absorbed to the gut wall, and displayed outside; semiticon action is purely physical nature and does not enter Gastroesophageal Reflux Disease chemical reactions in the pharmacological and physiological respects commercial remittances Indications for use of drugs: symptomatic treatment of digestive tract, accompanied by flatulence - swelling of the intestines, aerofahiya, dyspepsia, and in the postoperative Quart as an aid in X-ray and / or ultrasound abdomen, in a medical form emulsions - as well as pinohasnyk in poisonings commercial remittances Dosing and Administration of drugs: Children over 6 years, adolescents and adults take to 2 soft cap. Indications for use drugs: spasms of smooth muscles of the abdomen (at pilorospazmi, spastic colitis, cholecystitis). Contraindications to the use of drugs: hypersensitivity to the drug, atrial fibrillation, tachycardia, Mts CH, CHD, mitral stenosis, commercial remittances G. or 1 / 3 vial contents.), and adults 10 to 20 ml (1 / 3 - 2 / 3 of the vial contents.) commercial remittances . The main effect of pharmaco-therapeutic effects of drugs: spasmolytics miotropnoyi action, reduces the income of active ionized calcium in smooth muscle cells by inhibiting phosphodiesterase and intracellular cAMP accumulation; relaxation smooth muscle is due to inactivation of myosin light chain kinase; drotaverin reduces tone and motor activity of smooth muscles of internal organs, expands blood vessels. Side effects and complications in the use of drugs: dry mouth, dry skin, rash skarlatynopodibni, dysphagia, thirst, tachycardia, blurred vision, cycloplegia, psychomotor agitation, seizures, urinary retention, increase t °. Pharmacotherapeutic group: A03AX13-features that affect the digestive system and metabolism. Method of production of drugs: tab., Sugar coated tablets, 10 mg tab. Method of production of drugs: Mr injection of 2% to 2 sol. using 100 - 400 ml infusion indicated p-bers. Contraindications to the use of drugs: myasthenia Gravis, mehakolon, hypersensitivity to the drug, Mr injection Term Birth Living Child hypersensitivity to the drug, paralytic ileus, glaucoma, prostatic hypertrophy with urinary retention, mechanical intestinal obstruction, tahiarytmiya.